稳健医疗
(300888)
| 流通市值：71.10亿 | | | 总市值：235.90亿 |
| 流通股本：1.76亿 | | | 总股本：5.82亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 6,070,042,979.07 | 4,033,505,104.33 | 1,909,017,281.07 | 8,185,022,057.2 |
| 营业收入 | 6,070,042,979.07 | 4,033,505,104.33 | 1,909,017,281.07 | 8,185,022,057.2 |
| 二、营业总成本 | 5,429,693,699 | 3,576,014,244.81 | 1,707,213,229.42 | 7,285,343,794.63 |
| 营业成本 | 3,147,921,084.71 | 2,068,470,442.58 | 999,874,135.44 | 4,174,597,287.74 |
| 税金及附加 | 51,874,966.65 | 36,656,279.12 | 16,313,320.76 | 66,413,470.87 |
| 销售费用 | 1,575,884,258.32 | 1,055,741,084.22 | 477,837,652.89 | 2,090,492,506.1 |
| 管理费用 | 467,737,889.63 | 309,446,026.4 | 151,789,137.17 | 693,647,621.42 |
| 研发费用 | 231,681,326.77 | 143,142,952.33 | 75,999,859.76 | 322,051,868.43 |
| 财务费用 | -45,405,827.08 | -37,442,539.84 | -14,600,876.6 | -61,858,959.93 |
| 其中:利息费用 | 37,659,208.17 | 24,015,659.66 | 11,255,576 | 63,441,562.69 |
| 其中:利息收入 | 89,713,485.54 | 57,012,846.01 | 23,584,993.14 | 133,913,862.72 |
| 加:公允价值变动收益 | 2,742,139.47 | 7,577,712.84 | 14,430,436.62 | 46,678,103.27 |
| 加:投资收益 | 54,167,596.14 | 33,445,096.19 | 14,686,022.3 | 127,342,880.98 |
| 资产处置收益 | 2,760,899.31 | 1,930,800.28 | 797,543.99 | 32,201,950.01 |
| 资产减值损失(新) | -59,278,366.15 | -55,975,503.16 | -17,745,343.35 | -393,762,054.87 |
| 信用减值损失(新) | -7,568,820.47 | -8,295,817.44 | -5,053,372.8 | 4,725,509.3 |
| 其他收益 | 50,294,318.36 | 37,282,933.1 | 17,354,528.51 | 101,105,274.61 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 683,467,046.73 | 473,456,081.33 | 226,273,866.92 | 817,969,925.87 |
| 加:营业外收入 | 6,975,454.11 | 6,143,356.51 | 2,253,121.57 | 16,618,496.48 |
| 减:营业外支出 | 7,856,872.48 | 6,218,160.01 | 4,766,165.47 | 84,742,148.34 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 682,585,628.36 | 473,381,277.83 | 223,760,823.02 | 749,846,274.01 |
| 减:所得税费用 | 96,390,675.76 | 67,151,050.24 | 30,247,700.49 | 121,301,087.57 |
| 六、净利润 | 586,194,952.6 | 406,230,227.59 | 193,513,122.53 | 628,545,186.44 |
| 持续经营净利润 | 586,194,952.6 | 406,230,227.59 | 193,513,122.53 | 628,545,186.44 |
| 归属于母公司股东的净利润 | 552,966,991.14 | 384,150,379.21 | 182,424,811.95 | 580,403,232.37 |
| 少数股东损益 | 33,227,961.46 | 22,079,848.38 | 11,088,310.58 | 48,141,954.07 |
| (一)基本每股收益 | 0.95 | 0.66 | 0.31 | 0.98 |
| (二)稀释每股收益 | 0.95 | 0.66 | 0.31 | 0.98 |
| 八、其他综合收益 | -15,872,749.61 | -5,381,735.14 | 1,028,878.34 | 2,623,741.12 |
| 归属于母公司股东的其他综合收益 | -8,897,740.91 | -2,931,540.14 | 599,560.21 | 1,432,591.3 |
| 九、综合收益总额 | 570,322,202.99 | 400,848,492.45 | 194,542,000.87 | 631,168,927.56 |
| 归属于母公司股东的综合收益总额 | 544,069,250.23 | 381,218,839.07 | 183,024,372.16 | 581,835,823.67 |
| 归属于少数股东的综合收益总额 | 26,252,952.76 | 19,629,653.38 | 11,517,628.71 | 49,333,103.89 |
| 公告日期 | 2024-10-29 | 2024-08-28 | 2024-04-25 | 2024-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |